Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
about
Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapyFcγRIIB and autoimmunity.The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis.Citrulline-modified phage display: a novel high-throughput discovery approach for the identification of citrulline-containing ligands.Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil.Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis.Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisDetection of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis patients undergoing total knee arthroplasty.Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.Cigarette Smoke Induces Immune Responses to Vimentin in both, Arthritis-Susceptible and -Resistant Humanized Mice.Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.A study on FoxP3 and Tregs in paired samples of peripheral blood and synovium in rheumatoid arthritis.Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia.A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes.Rheumatoid Arthritis: Early diagnosis and treatment outcomes.Detection and isolation of auto-reactive human antibodies from primary B cellsRheumatoid arthritis: Disease or syndrome?Low-affinity Fcgamma receptors, autoimmunity and infection.Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritisThe use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis.Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool.Biomarkers of rheumatoid arthritis: recent progress.Biomarkers of cartilage and surrounding joint tissue.Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.Cellular and molecular perspectives in rheumatoid arthritis.Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis.Spatiotemporal expression of endogenous TLR4 ligands leads to inflammation and bone erosion in mouse collagen-induced arthritis.Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study.Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.
P2860
Q28475972-401D6B8A-91FB-4A27-84AB-BFE51689D28EQ30981881-12E01C4E-6C25-4930-9B95-5756E9380539Q33669345-B736CD94-FBE8-4FF1-ADCA-06ABF3D82A99Q33902573-936F527A-70D1-40D1-A4D1-E9A685C5A1B5Q34114546-FB545D0C-8B7F-4C3F-AB8D-452F21547326Q34250833-9274AD3E-B3A4-4EE0-ACE9-C7B9F36BA924Q34452744-3FC53634-9B83-4D12-918E-8BE81B4B32EEQ34559803-A1254689-A427-4FF5-A29A-42D86C7E089FQ34586496-A152311D-D1EC-4528-BF8B-9E83DDDD657EQ35123760-585D0F80-CF9F-46A5-A2CB-35A01217850FQ35193733-88EB43FC-918C-4927-939C-EA88F5A27C15Q35207886-F71C836E-E080-46BE-86B8-C5CA356CFB9DQ35644094-01F96283-6B6E-42DD-8516-651687EA7647Q35677937-6F0F19E4-65E2-4AAB-85C4-BD7FDAA33156Q35907747-405A2369-5AFD-4479-915B-07CDE903DABBQ36098311-783FCE9A-82A3-4E26-BC3C-538DFD10DDA8Q36125082-6162A26F-1332-450B-A221-76E9750D084AQ36230539-BECFA92F-0BF0-4088-8901-5C2853DF10A7Q36534242-F8F3CF54-4611-4F1A-B437-D6549D7EB02FQ36841105-468BD4CC-2C62-4839-ACBC-B3BF78B1C6F0Q37076880-FABEFBD8-5E17-42BB-A9AE-276F68A475FDQ37155766-D976EC73-28A7-41B4-92DA-B5FDD440A997Q37333073-64AF2118-9B5B-48E7-BEE5-C0E3DCE48106Q37358114-F4AF8FE8-1B45-4335-8172-832F6DD57F5EQ37578785-25E933C0-82E4-4E10-AA7A-5CBDA298EBB7Q37693747-C7E8FB27-E0EB-4AD4-A4E4-40D46A76BFD0Q37710782-86C46C7C-F4FF-4D5D-AAF6-DE1361395AB1Q37736263-3A285DF5-F9AC-476C-A8C7-0F0438D0E9FDQ37998089-4CF23773-58AC-400D-A902-28E2BF0252E2Q38078245-E9B7EC1F-E9C2-4BDD-B1B9-5287BF0C3E25Q38089869-D372E7F9-0253-429A-A7D3-F1A405983C9FQ38239828-1EB14E19-37EA-4738-B5D3-6F25C1D7E0F0Q38543383-BD70AEB1-DB33-4B8B-BC2E-E1233077CE48Q38650628-9BA7B4A4-F2CD-4668-821C-E7DFC65C1B07Q39308974-DD5CE221-6CC6-434D-B068-5A23325A2778Q39364674-3C1D724A-483D-40B1-83A1-9E2221703A5AQ39503170-72F5DC69-55F5-4024-BD86-242191AE79B0Q40894158-6D4990C6-A674-49CD-A601-5ED75814968DQ40976667-4DAF7EC4-E2AF-4BBC-816A-76B2776029C3Q41836190-7498DEF6-99DD-4460-8399-CF5174BD17FF
P2860
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@ast
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@en
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@nl
type
label
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@ast
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@en
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@nl
prefLabel
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@ast
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@en
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@nl
P2093
P2860
P356
P1476
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
@en
P2093
Ger J M Pruijn
Joyce J B C van Beers
Walther J van Venrooij
P2860
P304
P356
10.1196/ANNALS.1443.013
P407
P577
2008-11-01T00:00:00Z